Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P BERNASCONI

Showing results (251-260 of 314) with videos related to

Pageof 32
Sort By:
Journal of the Neurological Sciences|October 1, 1995
Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotypeL Morandi, M Mora, V Confalonieri, et al.
Bone Marrow Transplantation|January 1, 1993
In situ hybridization to detect chimerism and the origin of relapse in sex-mismatched allogeneic bone marrow transplantationP Bernasconi, M Boni, C Campagnoli, et al.
Seminars in Hematology|July 1, 1993
Evolving approaches with interferon alfa in chronic myelogenous leukemiaE Morra, G Alimena, M Lazzarino, et al.
Cancer Treatment Reviews|January 1, 1988
Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A)G Alimena, E Morra, M Lazzarino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's diseaseE Brusamolino, E Orlandi, A Canevari, et al.
Blood|August 1, 1988
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationG Alimena, E Morra, M Lazzarino, et al.
Annales De Cardiologie Et D'Angeiologie|June 1, 1987
[Streptobacillus moniliformis endocarditis. Apropos of 2 cases]J L Rey, G Laurans, A Pleskof, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemiaG Alimena, E Morra, M Lazzarino, et al.
Bone Marrow Transplantation|November 2, 2004
Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignanciesE P Alessandrino, P Bernasconi, A A Colombo, et al.
American Journal of Medical Genetics|December 4, 1995
DMD and BMD in the same family due to distinct mutationsL Morandi, M Mora, S Tedeschi, et al.
Pageof 32

Showing results (251-260 of 314) with videos related to

Sort By:
Pageof 32
Journal of the Neurological Sciences|October 1, 1995
Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotypeL Morandi, M Mora, V Confalonieri, et al.
Bone Marrow Transplantation|January 1, 1993
In situ hybridization to detect chimerism and the origin of relapse in sex-mismatched allogeneic bone marrow transplantationP Bernasconi, M Boni, C Campagnoli, et al.
Seminars in Hematology|July 1, 1993
Evolving approaches with interferon alfa in chronic myelogenous leukemiaE Morra, G Alimena, M Lazzarino, et al.
Cancer Treatment Reviews|January 1, 1988
Treatment of Ph'-positive chronic myelogenous leukemia (CML) with recombinant interferon alfa-2b (Intron A)G Alimena, E Morra, M Lazzarino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's diseaseE Brusamolino, E Orlandi, A Canevari, et al.
Blood|August 1, 1988
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationG Alimena, E Morra, M Lazzarino, et al.
Annales De Cardiologie Et D'Angeiologie|June 1, 1987
[Streptobacillus moniliformis endocarditis. Apropos of 2 cases]J L Rey, G Laurans, A Pleskof, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemiaG Alimena, E Morra, M Lazzarino, et al.
Bone Marrow Transplantation|November 2, 2004
Reduced-intensity conditioning regimen with thiotepa and fludarabine followed by allogeneic blood stem cell transplantation in haematological malignanciesE P Alessandrino, P Bernasconi, A A Colombo, et al.
American Journal of Medical Genetics|December 4, 1995
DMD and BMD in the same family due to distinct mutationsL Morandi, M Mora, S Tedeschi, et al.
Pageof 32